Related Experiment Video
Updated: Mar 8, 2026
Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
miR-155 contributes to Df1-induced asthma by increasing the proliferative response of Th cells via CTLA-4
Yingying Zhang1, Entao Sun2, Xueqin Li3
1Laboratory Medicine of Yijishan Hospital, Wannan Medical College, Wuhu 241001, PR China.
Abstract:
Allergen-induced airway inflammation is characterized by Th2-mediated eosinophilic inflammation in the lungs. While the molecular mechanisms leading to this abnormal Th2 response remain unclear. Recent studies have demonstrated that MicroRNAs (miRNAs) modulate allergic airway inflammation. In this study, the role of miRNAs in allergic asthma pathogenesis was examined. Differentially expressed miRNAs were identified via miRNA microarray, with miR-155 being among the most highly expressed in asthma mice lungs. Examination of miR-155 overexpression resulted in enhanced inflammation and mucus hypersecretion in the lungs of allergen-challenged mice compared with control animals. Furthermore, CTLA-4, an important negative regulator of T-cell activation, was identified as a direct miR-155 target. Moreover, miR-155 overexpression in CD4+ T cells resulted in decreased CTLA-4 levels and a subsequent increased proliferative response. Collectively, these findings suggest that miR-155 might contribute to allergic asthma by increasing the proliferative response of Th cells via CTLA-4 downregulation and thus may be a potential therapeutic target for allergic asthma.
Insights
MicroRNAs regulate allergic airway inflammation. This study found that miR-155 exacerbates asthma by increasing T-cell proliferation through CTLA-4 downregulation, suggesting miR-155 as a potential therapeutic target.
Area of Science:
- Immunology
- Molecular Biology
- Respiratory Medicine
Background:
- Allergen-induced airway inflammation, a hallmark of asthma, involves Th2-mediated eosinophilic responses.
- The precise molecular drivers of aberrant Th2 responses in asthma remain incompletely understood.
- MicroRNAs (miRNAs) have emerged as critical regulators of allergic airway inflammation.
Purpose of the Study:
- To investigate the role of specific microRNAs (miRNAs) in the pathogenesis of allergic asthma.
- To identify key miRNAs involved in allergen-induced airway inflammation and their molecular targets.
Main Methods:
- Utilized miRNA microarray to identify differentially expressed miRNAs in a mouse model of asthma.
- Examined the functional consequences of miR-155 overexpression in allergen-challenged mice.
- Investigated the regulatory relationship between miR-155 and CTLA-4 in CD4+ T cells.
Main Results:
- miR-155 was significantly upregulated in the lungs of asthma model mice.
- Overexpression of miR-155 led to increased pulmonary inflammation and mucus hypersecretion.
- CTLA-4 was identified as a direct target of miR-155, and its downregulation in T cells enhanced proliferation.
Conclusions:
- miR-155 contributes to allergic asthma pathogenesis by promoting T-cell hyperresponsiveness via CTLA-4 downregulation.
- miR-155 represents a potential therapeutic target for managing allergic asthma.
Related Concept Videos
01:20Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:26Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:24T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
01:29Asthma-I: Introduction